Telix Pharmaceuticals (TLX) Inventory (2023 - 2025)

Telix Pharmaceuticals (TLX) has disclosed Inventory for 3 consecutive years, with $37.1 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 48.65% to $37.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.1 million through Dec 2025, up 48.65% year-over-year, with the annual reading at $37.1 million for FY2025, 56.99% up from the prior year.
  • Inventory for Q4 2025 was $37.1 million at Telix Pharmaceuticals, up from $24.9 million in the prior quarter.
  • The five-year high for Inventory was $37.1 million in Q4 2025, with the low at $11.3 million in Q4 2023.
  • Average Inventory over 3 years is $24.4 million, with a median of $24.9 million recorded in 2024.
  • The sharpest move saw Inventory surged 121.36% in 2024, then surged 48.65% in 2025.
  • Over 3 years, Inventory stood at $11.3 million in 2023, then skyrocketed by 121.36% to $24.9 million in 2024, then soared by 48.65% to $37.1 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $37.1 million, $24.9 million, and $11.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.